Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Knees by Quarter
Knees (Triathlon Primary/Revision & Mako Robotic Knee Implants) — International Net Sales ($M) ($M)
Stryker Knees: $177M in Q3 2026, up 0.6% from a year earlier.
Latest, Q3 2026
177
Period ended Sep 30, 2026
Change on a year earlier
+0.6%
176 in Q3 2025
History
21 quarters
Since Q1 2021
Sources
7
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules, Recast 8-K & Form 10-K/10-Q Note 15.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Knees (Triathlon Primary/Revision & Mako Robotic Knee Implants) — International Net Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 177 | +0.6% | 0000310764-26-000059|sykex991earningsq32026.htm ↗ |
| Q2 2026 | Jun 30, 2026 | 205 | +13.9% | 0000310764-26-000048|sykex991earningsq22026.htm ↗ |
| Q1 2026 | Mar 31, 2026 | 198 | +13.1% | 0000310764-26-000031|syk-20260331.htm ↗ |
| Q4 2025 | Dec 31, 2025 | 201 | +12.9% | ir|change_in_pres_2026Q1 ↗ |
| Q3 2025 | Sep 30, 2025 | 176 | +15.0% | ir|change_in_pres_2026Q1 ↗ |
| Q2 2025 | Jun 30, 2025 | 180 | +6.5% | ir|change_in_pres_2026Q1 ↗ |
| Q1 2025 | Mar 31, 2025 | 175 | +10.1% | ir|change_in_pres_2026Q1 ↗ |
| Q4 2024 | Dec 31, 2024 | 178 | +10.6% | ir|change_in_pres_2026Q1 ↗ |
| Q3 2024 | Sep 30, 2024 | 153 | +17.7% | ir|change_in_pres_2026Q1 ↗ |
| Q2 2024 | Jun 30, 2024 | 169 | +8.3% | ir|change_in_pres_2026Q1 ↗ |
| Q1 2024 | Mar 31, 2024 | 159 | +6.0% | ir|change_in_pres_2026Q1 ↗ |
| Q4 2023 | Dec 31, 2023 | 161 | – | ir|change_in_pres_2026Q1 ↗ |
| Q3 2023 | Sep 30, 2023 | 130 | +12.1% | ir|change_in_pres_2026Q1 ↗ |
| Q2 2023 | Jun 30, 2023 | 156 | +18.2% | ir|change_in_pres_2026Q1 ↗ |
| Q1 2023 | Mar 31, 2023 | 150 | +26.1% | ir|change_in_pres_2026Q1 ↗ |
| Q3 2022 | Sep 30, 2022 | 116 | -1.7% | 0000310764-22-000105|syk-20220930.htm ↗ |
| Q2 2022 | Jun 30, 2022 | 132 | +5.6% | 0000310764-22-000092|syk-20220630.htm ↗ |
| Q1 2022 | Mar 31, 2022 | 119 | +0.8% | 0000310764-22-000062|syk-20220331.htm ↗ |
| Q3 2021 | Sep 30, 2021 | 118 | – | 0000310764-22-000105|syk-20220930.htm ↗ |
| Q2 2021 | Jun 30, 2021 | 125 | – | 0000310764-22-000092|syk-20220630.htm ↗ |
| Q1 2021 | Mar 31, 2021 | 118 | – | 0000310764-22-000062|syk-20220331.htm ↗ |
Breakdown
What makes up knees
Cite this data
StockData. (2026). Stryker Knees ($M), quarterly Q1 2021–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-knees-intl-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.